Related Experiment Video
Updated: Jun 27, 2026
13:19
Microarray-based Identification of Individual HERV Loci Expression: Application to Biomarker Discovery in Prostate Cancer
Published on: November 2, 2013
Persistent Hypercoagulability After Radical Prostatectomy: Biomarker Dynamics and Implications for Individualized
Matyas Benyo1, Marie Al-Muhanna2, Zsuzsanna Molnar1
1FertiMed LP Outpatient Center, 4027 Debrecen, Hungary.
Journal of Clinical Medicine
|June 26, 2026
Summary
Postoperative hypercoagulability after radical prostatectomy is prolonged, extending beyond hospital discharge. Biomarker-guided strategies are needed to personalize venous thromboembolism prophylaxis.
Area of Science:
- Urology
- Hematology
- Surgical Oncology
Background:
- Venous thromboembolism (VTE) is a significant complication following radical prostatectomy.
- Current VTE prophylaxis relies on fixed durations and static risk models, overlooking prolonged postoperative hypercoagulability.
Purpose of the Study:
- To review the pathophysiology and temporal dynamics of hypercoagulability post-radical prostatectomy.
- To highlight the gap between current thromboprophylaxis guidelines and biological realities.
Main Methods:
- Review of pathophysiological mechanisms of postoperative hypercoagulability.
- Emphasis on biomarker evidence (thrombin generation, von Willebrand factor).
- Analysis of temporal dynamics of haemostatic activation.
Main Results:
- Haemostatic activation can persist after hospital discharge, indicating a prolonged risk period.
- Existing risk models fail to account for dynamic haemostatic changes and biomarker data.
- A discrepancy exists between guideline-based prophylaxis and biological processes.
Conclusions:
- A conceptual framework for temporal, biomarker-guided thromboprophylaxis is proposed.
- Future studies should validate biomarker-guided strategies for individualized VTE prophylaxis.
- This approach may optimize prophylaxis for prostate cancer patients undergoing radical prostatectomy.
Related Concept Videos
01:29Venous Thrombosis III: Interprofessional Care
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
01:18Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
01:16Clot Retraction and Fibrinolysis
After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
01:30Venous Thrombosis IV: Nursing Management
Nursing management begins with a thorough assessment of the patient's health history. Key factors include trauma to veins, peripherally inserted central catheters, varicose veins, recent pregnancy or childbirth, surgery, bacteremia, prolonged bed rest, atrial fibrillation, COPD, heart failure, cancer, coagulation disorders, myocardial infarction, spinal cord injury, stroke, prolonged travel, recent bone fractures, and dehydration. Review medication intake, particularly oral contraceptives,...
01:24Disorders of Hemostasis
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.